BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34509365)

  • 1. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.
    Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR
    Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully automated analysis combining [
    Paprottka KJ; Kleiner S; Preibisch C; Kofler F; Schmidt-Graf F; Delbridge C; Bernhardt D; Combs SE; Gempt J; Meyer B; Zimmer C; Menze BH; Yakushev I; Kirschke JS; Wiestler B
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4445-4455. PubMed ID: 34173008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeatability of amide proton transfer-weighted signals in the brain according to clinical condition and anatomical location.
    Lee JB; Park JE; Jung SC; Jo Y; Kim D; Kim HS; Choi CG; Kim SJ; Kang DW
    Eur Radiol; 2020 Jan; 30(1):346-356. PubMed ID: 31338651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
    Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
    Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
    Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
    Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
    Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.
    Wu M; Jiang T; Guo M; Duan Y; Zhuo Z; Weng J; Xie C; Sun J; Li J; Cheng D; Liu X; Du J; Zhang X; Zhang Y; Liu Y
    Eur Radiol; 2024 May; 34(5):2986-2996. PubMed ID: 37855851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Dimensional Gradient-Echo-Based Amide Proton Transfer-Weighted Imaging of Brain Tumors: Comparison With Two-Dimensional Spin-Echo-Based Amide Proton Transfer-Weighted Imaging.
    Murayama K; Ohno Y; Yui M; Yamamoto K; Ikedo M; Ohba S; Hanamatsu S; Iwase A; Ikeda H; Hirose Y; Toyama H
    J Comput Assist Tomogr; 2023 May-Jun 01; 47(3):494-499. PubMed ID: 37185016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.
    Saini J; Gupta RK; Kumar M; Singh A; Saha I; Santosh V; Beniwal M; Kandavel T; Cauteren MV
    PLoS One; 2019; 14(4):e0215400. PubMed ID: 31017934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amide proton transfer weighted imaging in pediatric neuro-oncology: initial experience.
    Obdeijn IV; Wiegers EC; Alic L; Plasschaert SLA; Kranendonk MEG; Hoogduin HM; Klomp DWJ; Wijnen JP; Lequin MH
    NMR Biomed; 2024 Jun; 37(6):e5122. PubMed ID: 38369653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
    Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imaging.
    Zhang N; Kang J; Wang H; Liu A; Miao Y; Ma X; Song Q; Zhang L; Wang J; Shen Z; Xu X
    Clin Imaging; 2022 Jan; 81():15-23. PubMed ID: 34597999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of amide proton transfer imaging and magnetization transfer imaging in revealing glioma grades and proliferative activities: a histogram analysis.
    Su C; Jiang J; Liu C; Shi J; Li S; Chen X; Ao Q
    Neuroradiology; 2021 May; 63(5):685-693. PubMed ID: 32997164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
    Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
    Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of true progression from treatment response in high-grade glioma treated with chemoradiation: a comparison study of 3D-APTW and 3D-PcASL imaging and DWI.
    Hou H; Diao Y; Yu J; Xu M; Wang L; Li Z; Song T; Liu Y; Yuan Z
    NMR Biomed; 2023 Jan; 36(1):e4821. PubMed ID: 36031734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.
    Ma B; Blakeley JO; Hong X; Zhang H; Jiang S; Blair L; Zhang Y; Heo HY; Zhang M; van Zijl PC; Zhou J
    J Magn Reson Imaging; 2016 Aug; 44(2):456-62. PubMed ID: 26788865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.
    Hou H; Chen W; Diao Y; Wang Y; Zhang L; Wang L; Xu M; Yu J; Song T; Liu Y; Yuan Z
    Mol Imaging Biol; 2023 Apr; 25(2):343-352. PubMed ID: 35962302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion MR imaging for type I endometrial carcinoma: Correlation with Ki-67 proliferation status.
    Li Y; Lin CY; Qi YF; Wang X; Chen B; Zhou HL; Ren J; Yang JJ; Xiang Y; He YL; Xue HD; Jin ZY
    Magn Reson Imaging; 2021 May; 78():18-24. PubMed ID: 33556484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.